MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Key Facts

• SAN DIEGO--()--MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the grant of inducement stock options for an aggregate of 166,000 shares of the company’s common stock to six new employees.
• The stock options were granted as a material inducement to each new employee accepting employment with MEI in accordance with Nasdaq Listing Rule 5635(c)(4).
• The stock options have a $3.37 exercise price per share, which is equal to the closing price of the Company’s common stock on the grant date.
• The options were approved by the Company’s Compensation Committee of the Board of Directors in reliance on the employment inducement exception under Rule 5635(c)(4), which requires that grants relying on this exception be disclosed promptly in a press release.

Click To Read Full Article